857 related articles for article (PubMed ID: 22212900)
1. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.
Ensign LM; Cone R; Hanes J
Adv Drug Deliv Rev; 2012 May; 64(6):557-70. PubMed ID: 22212900
[TBL] [Abstract][Full Text] [Related]
2. Oral drug delivery with nanoparticles into the gastrointestinal mucosa.
Liu J; Leng P; Liu Y
Fundam Clin Pharmacol; 2021 Feb; 35(1):86-96. PubMed ID: 32749731
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.
Date AA; Hanes J; Ensign LM
J Control Release; 2016 Oct; 240():504-526. PubMed ID: 27292178
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers protecting toward an intestinal pre-uptake metabolism.
Suchaoin W; Bernkop-Schnürch A
Nanomedicine (Lond); 2017 Feb; 12(3):255-269. PubMed ID: 28093952
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
Pridgen EM; Alexis F; Farokhzad OC
Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Nanoparticle Transport across Intestinal Tissue: An Oral Delivery Perspective.
Ejazi SA; Louisthelmy R; Maisel K
ACS Nano; 2023 Jul; 17(14):13044-13061. PubMed ID: 37410891
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
8. Surface design of nanocarriers: Key to more efficient oral drug delivery systems.
Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A
Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780
[TBL] [Abstract][Full Text] [Related]
9. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.
Maisel K; Ensign L; Reddy M; Cone R; Hanes J
J Control Release; 2015 Jan; 197():48-57. PubMed ID: 25449804
[TBL] [Abstract][Full Text] [Related]
10. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.
Subramanian DA; Langer R; Traverso G
J Nanobiotechnology; 2022 Aug; 20(1):362. PubMed ID: 35933341
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
12. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
14. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery.
Leonaviciute G; Bernkop-Schnürch A
Expert Opin Drug Deliv; 2015; 12(11):1703-16. PubMed ID: 26477549
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micelles for oral drug delivery.
Gaucher G; Satturwar P; Jones MC; Furtos A; Leroux JC
Eur J Pharm Biopharm; 2010 Oct; 76(2):147-58. PubMed ID: 20600891
[TBL] [Abstract][Full Text] [Related]
16. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
17. Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.
Simões SM; Figueiras AR; Veiga F; Concheiro A; Alvarez-Lorenzo C
Expert Opin Drug Deliv; 2015 Feb; 12(2):297-318. PubMed ID: 25227130
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update.
Liu S; Wen X; Zhang X; Mao S
Expert Opin Drug Deliv; 2023; 20(10):1333-1347. PubMed ID: 37439101
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
[TBL] [Abstract][Full Text] [Related]
20. Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery.
Liu Y; Yang T; Wei S; Zhou C; Lan Y; Cao A; Yang J; Wang W
Int J Pharm; 2018 Feb; 537(1-2):245-256. PubMed ID: 29288808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
